R&D

BRILL PHARMA is committed to the research and development 

 of new therapies that contribute to improving the quality of life of people. 

R & D PROJECTS IN PROGRESS

  • BRILL PHARMA is researching in Spain, ongoing projects:

The damage to the cells of the retina by the wavelengths of blue light, which is the one emitted by most LED screens, is increasingly demonstrated.

BRILL PHARMA has underway the development of an eye drop to protect the cells of the retina from the LED light.

Traditional anti-inflammatory drugs have undesirable effects on the eye when used in the long term, BRILL PHARMA investigates a new category of eye anti-inflammatory drugs that allow their long-term use.

LogoBRENG-2-e1495540738470

Development of industrial equipment and production related to the intravitreal injection of assets.

Project related to the development of vehicles to improve the pharmacokinetics of assets deposited on the ocular surface.

PARTNERING IN R & D PROJECTS

BRILL PHARMA wants to collaborate with doctors and centers with new ideas of product development.

CONTACT US